Details for New Drug Application (NDA): 061578
✉ Email this page to a colleague
NDA 061578 describes POLY-RX, which is a drug marketed by X Gen Pharms and is included in one NDA. Additional details are available on the POLY-RX profile page.
The generic ingredient in POLY-RX is polymyxin b sulfate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
The generic ingredient in POLY-RX is polymyxin b sulfate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
Summary for 061578
| Tradename: | POLY-RX |
| Applicant: | X Gen Pharms |
| Ingredient: | polymyxin b sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061578
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;FOR RX COMPOUNDING | Strength | 100,000,000 UNITS/BOT | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
